Literature DB >> 16755379

Functional effects of neuromelanin and synthetic melanin in model systems.

K L Double1.   

Abstract

The function of the dark polymer pigment neuromelanin found in catecholaminergic neurons of the human brain is not understood, especially as most published data are based upon a synthetic model melanin which differs structurally to the native pigment. Nevertheless human neuromelanin has been shown to efficiently bind transition metals such as iron, as well as other potentially toxic molecules. The pigment may have a protective function in the healthy brain by, for example, contributing to iron homeostasis within pigmented nuclei. We have demonstrated that synthetic dopamine melanin stimulates cell damage in both cell lines and primary cells in vitro, an effect associated with increased hydroxyl radical production and apoptosis. In contrast, at low iron concentrations native neuromelanin does not induce cell damage but rather protects cells in culture from oxidative stress. This protective function appears to be lost at high iron concentrations where neuromelanin saturated with iron functions as a source of oxidative load, rather than an iron chelator. Changes to neuromelanin and tissue iron load in Parkinson's disease may decrease the protective potential of the pigment, thus increase the potential for cell damage in this disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755379     DOI: 10.1007/s00702-006-0450-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.

Authors:  D Offen; I Ziv; A Barzilai; S Gorodin; E Glater; A Hochman; E Melamed
Journal:  Neurochem Int       Date:  1997-08       Impact factor: 3.921

Review 2.  Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.

Authors:  D Ben-Shachar; M B Youdim
Journal:  J Neural Transm Suppl       Date:  1990

3.  Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells.

Authors:  Jie Li; Carsten Scheller; Eleni Koutsilieri; Francine Griffiths; Philip M Beart; Linda D Mercer; Glenda Halliday; Emma Kettle; Dominic Rowe; Peter Riederer; Manfred Gerlach; Michael Rodriguez; Kay L Double
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

4.  Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.

Authors:  T Shima; T Sarna; H M Swartz; A Stroppolo; R Gerbasi; L Zecca
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

5.  Magnetic investigations of human mesencephalic neuromelanin.

Authors:  F Bolzoni; S Giraudo; L Lopiano; B Bergamasco; M Fasano; P R Crippa
Journal:  Biochim Biophys Acta       Date:  2002-03-16

6.  Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Authors:  K L Double; L Zecca; P Costi; M Mauer; C Griesinger; S Ito; D Ben-Shachar; G Bringmann; R G Fariello; P Riederer; M Gerlach
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

Review 7.  The neuromelanin of human substantia nigra and its interaction with metals.

Authors:  L Zecca; D Tampellini; A Gatti; R Crippa; M Eisner; D Sulzer; S Ito; R Fariello; M Gallorini
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

8.  The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.

Authors:  M Zareba; A Bober; W Korytowski; L Zecca; T Sarna
Journal:  Biochim Biophys Acta       Date:  1995-06-09

9.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease.

Authors:  Henrik Wilms; Philip Rosenstiel; Jobst Sievers; Günther Deuschl; Luigi Zecca; Ralph Lucius
Journal:  FASEB J       Date:  2003-01-21       Impact factor: 5.191

View more
  13 in total

1.  Stress chaperone mortalin regulates human melanogenesis.

Authors:  Renu Wadhwa; Didik Priyandoko; Ran Gao; Nashi Widodo; Nupur Nigam; Ling Li; Hyo Min Ahn; Chae-Ok Yun; Nobuhiro Ando; Christian Mahe; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2016-04-07       Impact factor: 3.667

2.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

Review 3.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Authors:  Isidre Ferrer; Anna Martinez; Rosa Blanco; Ester Dalfó; Margarita Carmona
Journal:  J Neural Transm (Vienna)       Date:  2010-09-23       Impact factor: 3.575

4.  WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition.

Authors:  Hsiang Ho; Rubina Kapadia; Sejad Al-Tahan; Safoora Ahmad; Anand K Ganesan
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

5.  The expanding role and presence of neuromelanins in the human brain - why gray matter is gray.

Authors:  Vincent J Hearing
Journal:  Pigment Cell Melanoma Res       Date:  2008-12-19       Impact factor: 4.693

6.  Current understanding of the binding sites, capacity, affinity, and biological significance of metals in melanin.

Authors:  Lian Hong; John D Simon
Journal:  J Phys Chem B       Date:  2007-06-20       Impact factor: 2.991

7.  Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site.

Authors:  Mika Reinisalo; Jaana Putula; Eliisa Mannermaa; Arto Urtti; Paavo Honkakoski
Journal:  Mol Vis       Date:  2012-01-10       Impact factor: 2.367

8.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

9.  Complexity of dopamine metabolism.

Authors:  Johannes Meiser; Daniel Weindl; Karsten Hiller
Journal:  Cell Commun Signal       Date:  2013-05-17       Impact factor: 5.712

10.  Elemental characterisation of melanin in feathers via synchrotron X-ray imaging and absorption spectroscopy.

Authors:  Nicholas P Edwards; Arjen van Veelen; Jennifer Anné; Phillip L Manning; Uwe Bergmann; William I Sellers; Victoria M Egerton; Dimosthenis Sokaras; Roberto Alonso-Mori; Kazumasa Wakamatsu; Shosuke Ito; Roy A Wogelius
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.